From the very first minute, Angidak helps to reduce pain.*
* Simard-Savoie S, Forest D. Topical anaesthetic activity of benzydamine. Curr Ther Res. 1978; 23: 734–745
The product is prescribed during the therapy of inflammatory diseases of the oral cavity and ENT-organs.
In infectious and inflammatory diseases requiring systemic treatment, it is necessary to use the product as part of combination therapy.
Benzydamine hydrochloride (benzydamine). It is a non-steroidal anti-inflammatory drug.
The product has three forms of presentation:
All forms of the product should not be used by pregnant and breastfeeding women.
Angidak can be prescribed to children from 3 years old, Angidak sept – from 12 years old. Angidak forte is indicated only from the age of 18.
The duration of treatment is 7 days. If after 7 days of treatment there is no improvement, it is necessary to consult a healthcare professional.
Drug-to-drug interaction studies with other drugs have not been conducted.
A common contraindication for all forms of the product is hypersensitivity to benzydamine or other product ingredients.
Angidak sept is contraindicated in children under 12 years old, Angidak forte – in children under 18 years old.
Should be taken with caution: hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs, bronchial asthma (including history).
It should not be used during pregnancy and breast-feeding period.